Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lambert ...

moxa and ease / Thanks for the replies but I think you're wrong

in response to by
posted on Jun 20, 2007 07:39AM

I agree that S & L may be separate entities, however for the sake of PTSC shares, they are reported as one and NEITHER has sole voting power over their combined shares. Their combined shares are over the 5% Beneficial Ownership threshold (near 9.99%) and the DO report together in the S13G form. That's not a form that PTSC files but rather S&L files, see link

http://www.sec.gov/Archives/edgar/da...

Per this filing which they have filed the last 2 years, and per the proxy & prosepctus amendments, S&L's share counts INCLUDE the exercised warrants, which as I posted earlier, if you go back and add those up equal essentially the 38M shares accounted for in the above filing.

So I don't think S&L is selling. If they are, then SEC filings are being filed falsely from what I can tell. I'm not trying to defend S&L but only trying to verify what I believe is a s false assumption about who is selling.

Share
New Message
Please login to post a reply